Navigation Links
Scientists clarify origins of potato germplasm Neo-Tuberosum
Date:6/2/2010

This release is available in Spanish.

A recent study conducted by scientists with the Agricultural Research Service (ARS) and cooperators shows the potato germplasm Neo-Tuberosum, used by potato breeders to develop new cultivars, has origins that can be traced to Chile, not to the Andes as previously believed.

Native "landrace" potatoes come from two areas: lowland central Chile and the Andes mountains from Venezuela south to northern Argentina. These geographical groups of potato, Solanum tuberosum, differ mainly in day-length adaptationthe amount of daylight needed for them to tuberize or begin to develop. The Andean potato is adapted to short-day conditions widespread in the mountainous, tropical region from which it came. The Chilean potato, on the other hand, evolved under long-day conditions, making it pre-adapted to grow in other long-day-length environments like Europe and North America.

The Andean potato contains many desirable traits, such as virus X and Y resistance, earlier tuberization and greater yield. In the 1960s, an English potato breeder sought to take the Andean potato and adapt it for use in long-day-length regions. This new potato germplasm was named "Neo-Tuberosum" and is widely used by potato breeders to develop new potato varieties.

ARS botanist David Spooner, with the agency's Vegetable Crop Research Unit in Madison, Wis., and his colleagues at the International Potato Center in Lima, Peru, originally sought to measure how much the genetic base of modern potato varieties and breeders' lines had broadened with respect to the Andean and Chilean landraces.

Spooner and his collaborators unexpectedly found Neo-Tuberosum is not a product of strict inter-Andean breeding as previously believed. Instead, it's a descendant of the Chilean potato.

According to Spooner, the study, which was published in '/>"/>

Contact: Stephanie Yao
Stephanie.Yao@ars.usda.gov
301-504-1619
United States Department of Agriculture-Research, Education, and Economics
Source:Eurekalert

Page: 1 2

Related biology news :

1. Atmospheric scientists start monthlong air sampling campaign
2. Scripps research scientists determine structure of immune molecule that counteracts HIV strains
3. NYSCF awards fellowships to 8 innovative stem cell scientists
4. Scientists decipher structure of natures light switch
5. Scientists find genes associated with throat cancer through study of over 10,000 subjects
6. NIST scientists gain new core understanding of nanoparticles
7. Scientists conclude asteroid ended the age of dinosaurs
8. Scientists to study impact of gulf oil spill on marine food webs
9. Scripps Research scientists break barrier to creating potential therapeutic molecules
10. Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments
11. FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2015)... 13, 2015 ACT Genomics Co., Ltd., ... to transform cancer genomic information into precision diagnosis ... has raised US$ 8 million in the its first ... Taipei, Taiwan , ACT Genomics has ... the aim to implement next generation sequencing (NGS) ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
(Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35
... can lower the risk of cardiovascular morbidities. This is the ... current issue of Deutsches rzteblatt International (Dtsch Arztebl ... chloride is in excess of 6 g per day increase ... notable in view of the fact that in the Western ...
... like HIV, reproduces and assembles new viruses is different than ... Understanding the steps a virus takes for assembly could allow ... diseases. The team studied a chicken virus called Rous ... to HIV. "The question is, how do retroviruses build ...
... long-term need for anticoagulant drug therapies may soon find help ... commonly known by the trade-name Plavix. Researchers in the ... clopidogrel may be a safe and effective treatment for dogs ... offer a safe alternative to NSAIDs for treating dogs at ...
Cached Biology News:Retrovirus replication process different than thought 2Plavix may be treatment for dogs at risk of thromboembolic disease 2
(Date:3/2/2015)... MENLO PARK, Calif. , March 2, 2015 /PRNewswire/ ... company in the emerging field of regenerative medicine, today ... year 2014 financial and operating results on Tuesday, March ... markets. The Company will host a conference call and ... Eastern / 1:30 p.m. Pacific to discuss the results ...
(Date:3/2/2015)... Global Stem Cells Group.com has ... Bioengineering Co., Ltd. and its Chinese-American founder Mingjie ... stem cells training course in the City of ... Shenzhen HANK is a biotechnology company established in ... virologist, to integrate research, development, production, and sales ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Increasing its efforts ... Films launches its first three episodes of The GMO TRUTH ... Project this month, as it continues its mission to discover ... the project's first phase, to “uncover the truth about the ... media. , The GMO Truth Podcast is an expansion of ...
(Date:2/27/2015)... 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... for its newly developed Bruton,s tyrosine kinase (BTK) ... completed. The results of these preclinical evaluations have ... Administration. The feedback received from the Agency is ... study. Additional preclinical work is required to begin ...
Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
... Avantium announced today the,successful completion of ... Avantium,is active in the development and commercialization ... and the improvement of,pharmaceutical products. The financing ... development programs. The focus of the next-generation ...
... and DUBLIN, Ireland, Oct. 29 ,Shire plc (LSE: SHP, Nasdaq: SHPGY) ... September 30, 2008., Q3 2008 Financial Highlights, - ... excluding ADDERALL XR(R) up 51% to $444 million - New ... 22%) - Total revenues up 28% to $779 million ...
... Oct. 29 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), ... that it,is scheduled to present at two upcoming ... in New York City and the,Credit Suisse Asian ... Wu, Senior Financial Manager, is scheduled to present ...
Cached Biology Technology:Avantium Completes EUR 18 Million Financing Round 2Avantium Completes EUR 18 Million Financing Round 3Avantium Completes EUR 18 Million Financing Round 4Shire's New Product Portfolio Delivers Strong Quarterly Performance 2Shire's New Product Portfolio Delivers Strong Quarterly Performance 3Shire's New Product Portfolio Delivers Strong Quarterly Performance 4Shire's New Product Portfolio Delivers Strong Quarterly Performance 5Shire's New Product Portfolio Delivers Strong Quarterly Performance 6Shire's New Product Portfolio Delivers Strong Quarterly Performance 7Shire's New Product Portfolio Delivers Strong Quarterly Performance 8Shire's New Product Portfolio Delivers Strong Quarterly Performance 9Shire's New Product Portfolio Delivers Strong Quarterly Performance 10Shire's New Product Portfolio Delivers Strong Quarterly Performance 11Shire's New Product Portfolio Delivers Strong Quarterly Performance 12Shire's New Product Portfolio Delivers Strong Quarterly Performance 13Shire's New Product Portfolio Delivers Strong Quarterly Performance 14Shire's New Product Portfolio Delivers Strong Quarterly Performance 15Shire's New Product Portfolio Delivers Strong Quarterly Performance 16Shire's New Product Portfolio Delivers Strong Quarterly Performance 17Shire's New Product Portfolio Delivers Strong Quarterly Performance 18Shire's New Product Portfolio Delivers Strong Quarterly Performance 19Shire's New Product Portfolio Delivers Strong Quarterly Performance 20Shire's New Product Portfolio Delivers Strong Quarterly Performance 21Shire's New Product Portfolio Delivers Strong Quarterly Performance 22Shire's New Product Portfolio Delivers Strong Quarterly Performance 23Shire's New Product Portfolio Delivers Strong Quarterly Performance 24Shire's New Product Portfolio Delivers Strong Quarterly Performance 25Shire's New Product Portfolio Delivers Strong Quarterly Performance 26Shire's New Product Portfolio Delivers Strong Quarterly Performance 27Shire's New Product Portfolio Delivers Strong Quarterly Performance 28Shire's New Product Portfolio Delivers Strong Quarterly Performance 29Shire's New Product Portfolio Delivers Strong Quarterly Performance 30Shire's New Product Portfolio Delivers Strong Quarterly Performance 31Shire's New Product Portfolio Delivers Strong Quarterly Performance 32Shire's New Product Portfolio Delivers Strong Quarterly Performance 33
lid holder -see Blotters (Semi-Dry) for more info...
... the consumable measurement plate for ... individually controlled measurement sites. Each ... liquid flow channel system that ... solution and compound applications necessary ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... solutions to meet your laboratory's requirements for data management and quality control. ... ... ... CLARA® is the standard software for Staccato Systems and custom Allegro Modules allowing for the simple ...
Biology Products: